PMID: 2093690Jan 1, 1990Paper

Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status

International Urology and Nephrology
A AkdaşT Akoğlu

Abstract

Serum and urine levels of tumour necrosis factor (TNF) which is a lymphokine was measured in patients with genitourinary cancer (either prostatic, bladder or testicular carcinoma) in order to find out whether there were elevated levels of TNF in those patients and if it was related to disease status. Although the preliminary results are not conclusive, further research on TNF may prove this immunoprotein to be a potential diagnostic and therapeutic agent.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Jun 9, 1988·The New England Journal of Medicine·H R MichieD W Wilmore
Jan 1, 1987·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·T KawaiM Suzuki
Mar 1, 1987·Journal of Leukocyte Biology·M R ShalabyB B Aggarwal
Jun 9, 1988·The New England Journal of Medicine·E J Ziegler
Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L ShermanD W Kufe
Jan 1, 1987·Ciba Foundation Symposium
Feb 12, 1987·The New England Journal of Medicine·B Beutler, A Cerami
Jan 1, 1986·Journal of Immunopharmacology·D A Flick, G E Gifford
Oct 1, 1981·Equine Veterinary Journal·R R Pascoe, P M Summers
Jan 1, 1981·Annals of the New York Academy of Sciences·G IorioM Rossi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.